CIRON DRUGS AND PHARMACEUTICALS PVT LTD
FDA inspection history in Tarapur, India, 2022 to 2023
- 2
- Form 483s
Every document, by year
- Form 483
2022: one Form 483; 2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2022–23Two Form 483s, at Tarapur, India.
- 2022The longest 483 on file: 4 observations over 5 pages at Tarapur, India.
Cited most
Across all CIRON DRUGS AND PHARMACEUTICALS PVT observations on file
- 21 CFR 211.113Control of microbiological contamination2
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.160General requirements1
- 21 CFR 211.42Design and construction features1
- 21 CFR 211.46Ventilation, air filtration, air heating and cooling1
The complete CIRON DRUGS AND PHARMACEUTICALS PVT file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Tarapur, India
Two Form 483s · 2022 to 2023 · 6 observations
Latest: Form 483, Apr 25, 2023 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-04-25 | 483 Form 483 | Tarapur, India | 2 | $99 |
| 2022-09-21 | 483 Form 483 | Tarapur, India | 4 | $99 |
Investigators on these documents
FEI number 3017545500 · most recent document Apr 25, 2023
About CIRON DRUGS AND PHARMACEUTICALS PVT LTD
How many FDA Form 483s has CIRON DRUGS AND PHARMACEUTICALS PVT LTD received?
FDA Intel has 2 Form 483s on file for CIRON DRUGS AND PHARMACEUTICALS PVT LTD; the most recent is dated Apr 25, 2023.
When was CIRON DRUGS AND PHARMACEUTICALS PVT LTD last inspected by FDA?
The most recent FDA inspection document on file for CIRON DRUGS AND PHARMACEUTICALS PVT LTD is a Form 483 dated Apr 25, 2023, for the site in Tarapur, India.
What did FDA cite at CIRON DRUGS AND PHARMACEUTICALS PVT LTD?
The regulations cited most in the observations on file for CIRON DRUGS AND PHARMACEUTICALS PVT LTD are 21 CFR 211.113 (Control of microbiological contamination), 2 times; 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 1 time; 21 CFR 211.160 (General requirements), 1 time.